Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Examining the impact of deductibles on prescription drug utilization and costs: a quasi-experimental study using administrative data from British Columbia

FY 2021-22

Summary
Prescription drugs are the second largest contributor to health spending in Canada. Prescription drug coverage is an important topic in Canadian health policy debates, especially because most funding for drugs comes from private sources. To protect patients from extreme costs, several provinces offer public drug insurance plans with high deductibles (they require patients to pay a substantial amount out-of-pocket before receiving public coverage). Despite the widespread use of deductibles, we know embarrassingly little about their impacts on patients and the health system.The objective of my research is to evaluate the impact of an income-based deductible on patients prescription drug use and costs as well as health service use and associated costs. I will do this using administrative data and a natural experiment emergent from the design of the universal Fair PharmaCare program in British Columbia (BC). As of 2019, Fair PharmaCare imposes no deductible on families with incomes less than $30 000, but families with incomes just over $30 000 face a $650 deductible. Given that patients with family incomes just above and below $30 000 are likely very similar, whether they face a $0 or $650 deductible is essentially random. This near randomization results in a natural experiment. I will use a powerful analytical tool known as regression discontinuity (RD) to exploit this natural experiment to determine the impact of the deductible. Specifically, I will apply RD analysis to a large administrative dataset from BC to estimate the impact of the deductible on prescription drug use and costs as well as health service use and associated costs.My research will help inform the design of drug insurance programsspecifically with respect to deductiblesin Canada and abroad.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466662
Name
Sharma Kartik
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Examining the impact of deductibles on prescription drug utilization and costs: a quasi-experimental study using administrative data from British Columbia
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Administrative Data; Big Data; Deductibles; Health Policy; Insurance; Pharmaceuticals; Quantitative; Quasi-Experimental; Regression Discontinuity
Abstract
Prescription drugs are the second largest contributor to health spending in Canada. Prescription drug coverage is an important topic in Canadian health policy debates, especially because most funding for drugs comes from private sources. To protect patients from extreme costs, several provinces offer public drug insurance plans with high deductibles (they require patients to pay a substantial amount out-of-pocket before receiving public coverage). Despite the widespread use of deductibles, we know embarrassingly little about their impacts on patients and the health system.The objective of my research is to evaluate the impact of an income-based deductible on patients prescription drug use and costs as well as health service use and associated costs. I will do this using administrative data and a natural experiment emergent from the design of the universal Fair PharmaCare program in British Columbia (BC). As of 2019, Fair PharmaCare imposes no deductible on families with incomes less than $30 000, but families with incomes just over $30 000 face a $650 deductible. Given that patients with family incomes just above and below $30 000 are likely very similar, whether they face a $0 or $650 deductible is essentially random. This near randomization results in a natural experiment. I will use a powerful analytical tool known as regression discontinuity (RD) to exploit this natural experiment to determine the impact of the deductible. Specifically, I will apply RD analysis to a large administrative dataset from BC to estimate the impact of the deductible on prescription drug use and costs as well as health service use and associated costs.My research will help inform the design of drug insurance programsspecifically with respect to deductiblesin Canada and abroad.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sharma, Kartik
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~